[Clinical Talks] When ends meet, molecular tools for clinical good
May 12 @ 09:00 – 09:30 CEST
Ulf Landegren received his MD and PhD in Uppsala, Sweden, before spending five years at California Institute of Technology. As professor of molecular medicine in Uppsala his research focuses on developing molecular tools to meet needs in basic research and medicine, from analyses of genetic variation with techniques such as oligonucleotide ligation assays and padlock probes to protein assays using oligonucleotide-conjugated antibodies in proximity assays for measuring protein expression levels in liquid samples or imaging their distribution in situ. Professor Landegren is a member of EMBO, the Royal Swedish Academy of Sciences and the Royal Society of Sciences at Uppsala. He is member of several academic or industrial boards and advisory boards. He has authored 230 peer-reviewed publications, and he is inventor of some 50 patents or applications. Work in his lab has so far given rise to 12 spin-out companies with a combined staff of more than 900 people, including two companies that are publicly traded (Olink Proteomics and Q-linea). Technologies from his lab have also been licensed to many leading international biotech and diagnostic companies.
Moderator: Michael Akhras
Clinical Talks is back for more! With a brand new and shiny Season 6. After successfully completing 5 seasons with > 70 enthusiastic Clinical Talkers to our record, we have barely scratched the surface of all the amazing work our clinical, academic and industry Life Science community has to offer. More about the upcoming events is available here.